Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
BRIEF COMMUNICATION
You have accessRestricted Access

Proximal Tubular Cysts in Fetal Human Autosomal Recessive Polycystic Kidney Disease

KOICHI NAKANISHI, WILLIAM E. SWEENEY, KLAUS ZERRES, LISA M. GUAY-WOODFORD and ELLIS D. AVNER
JASN April 2000, 11 (4) 760-763; DOI: https://doi.org/10.1681/ASN.V114760
KOICHI NAKANISHI
*
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLIAM E. SWEENEY JR
*
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KLAUS ZERRES
†
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LISA M. GUAY-WOODFORD
‡
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELLIS D. AVNER
*
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Abstract. Standard texts describe human autosomal recessive polycystic kidney disease (ARPKD) as a cystic kidney disease in which lesions are localized to collecting tubules. Murine models of ARPKD consistently demonstrate an early phase of proximal tubular (PT) cystic involvement, which disappears shortly after birth. This is followed by a phase of collecting tubular (CT) cyst formation and progressive enlargement leading to compromise of renal function and death. Because the description of cystic lesions in human ARPKD has been largely based on postnatal specimens, PT cyst formation was hypothesized to be a characteristic feature of fetal human, as well as murine, ARPKD. This study examines nephron segment-specific cyst localization histochemically by lectin binding in 11 human ARPKD specimens obtained at different fetal and postnatal ages. PT cysts were found in human fetal specimens from gestational age 14 wk to 26 wk. The percentage of cysts involving PT segments ranged from 2 to 41%. The cystic index of PT cysts ranged from 2 to 5. In all specimens in which PT cysts were found, both the percentage of CT cysts and their cystic index were equal to or greater than the percentage of PT cysts and the associated PT cystic index. PT cysts were absent in all kidney specimens older than 34 wk gestational age. It is concluded that human ARPKD, like murine ARPKD, has a transient phase of PT cyst formation during early fetal development.

Autosomal recessive polycystic kidney disease (ARPKD) is one of a number of human genetic and acquired diseases in which renal cysts are a central pathologic feature. Although standard texts (1,2) describe human ARPKD as a cystic kidney disease in which lesions are localized to collecting tubules, murine models of ARPKD, C57BL/6J-cpk/cpk (cpk), BALB c-bpk/bpk (bpk), and FVB/N-orpk/orpk (orpk) (3,4,5) consistently demonstrate an early phase of proximal tubular (PT) cystic involvement, which disappears shortly after birth. This is followed by a phase of collecting tubular (CT) cyst formation and progressive enlargement leading to compromise of renal function and death. Because description of cystic lesions in human ARPKD has been largely based on postnatal specimens, we hypothesized that PT cyst formation may be a characteristic feature of fetal human, as well as murine, ARPKD. We therefore examined nephron segment-specific cyst localization in human ARPKD specimens obtained at different fetal and post-natal ages. The results demonstrate that human ARPKD, like murine ARPKD, has a transient phase of PT cyst formation during fetal development.

Materials and Methods

Specimens: ARPKD Diagnosis

We examined 11 kidney specimens of human ARPKD from nine families. ARPKD was diagnosed in all cases by consensus histopathologic, clinical, radiographic, and genetic criteria (6). Fresh ARPKD specimens 2 (gestational age 17 wk [GA17]), 4 (GA20), 8 (GA24), and 11 (postnatal age 12 wk [PA12]) were fixed immediately after harvesting in 4% paraformaldehyde, embedded in Immuno-bed (Polysciences, Warrington, PA) plastic resin, and sectioned at 4 μm. The remaining human ARPKD specimens were received as formalin-fixed, paraffin-embedded blocks, which were then sectioned at 6 μm. Normal kidney specimens were received as a formalin-fixed, paraffin-embedded blocks and used as a control.

Immunohistochemistry

Cyst localization was examined using our previously described segment-specific lectin binding method with biotin-labeled Lotus Tetragonobolus (LTA; Sigma Chemical Co., St. Louis, MO) as a marker for proximal tubules (visualized with Fast Red) and biotin-labeled Arachis Hypogaea (PNA; Sigma Chemical Co.) as a marker for collecting tubules (visualized with diaminobenzidine) (3,4,7,8,9).

Lectin Profile Analysis of Cyst Formation and Cystic Index

After immunohistologic preparation, LTA and PNA lectin profile analyses were performed on the kidney sections of human ARPKD. Published data and morphometric analyses in our laboratory of normal fetal lectin-identified PT and CT diameters established a mean PT diameter of 0.010 ± 0.004 mm (range, 0.004 to 0.020) at GA14, which increased only slightly to 0.013 ± 0.006 mm (range, 0.006 to 0.025) at PA12 (10). PT luminal diameter had to exceed the mean diameter by twofold and the highest normal value by 1.5-fold to be considered cystic. The degree of tubular cyst formation was quantified by utilization of a cystic index. The index has been derived from basic light microscopic morphometric methods (11) and has been standardized to quantify cyst formation in vivo and in vitro (3,4,7,8,9). After routine histologic preparation, 10 to 12 evenly spaced 4-μm sections were graded for cyst formation in LTA-positive tubular segments (PT) or in PNA-positive tubular segments (CT), on the following scale (9): 0, no cysts observed; 1, single or multiple cysts >0.03 and ≤0.05 mm; 2, multiple cysts >0.05 and ≤0.10 mm; 3, multiple cysts >0.10 and ≤0.15 mm; 4, multiple cysts >0.15 and ≤0.20 mm; 5, multiple cysts >0.20 mm.

The numbers of LTA-positive, PNA-positive, and total cysts were counted in six separate fields having more than 40 glomeruli, with low-power magnification (×32).

Results

PT cysts were found in human fetal specimens from GA14 to GA26. PT cysts were absent in specimen 10 (GA34) and specimen 11 (PA12). Representative photos from specimens 2 (GA17), 4 (GA20), 8 (GA24), and 11 (PA12) are shown in Figure 1. The percentage of cysts involving PT and CT segments ranged from 0 to 41% and from 52 to 96%, respectively. During successive fetal stages, there was a gradual shift in the site of cystic nephron involvement, from PT to CT, as defined by lectin binding. The cystic index of PT cysts ranged from 0 to 5. In all specimens in which PT cysts were found, the percentage of CT cysts and their cystic index was equal to or greater than the percentage of PT cysts and the associated PT cystic index (Table 1).

             Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Proximal tubular (PT) cysts in human autosomal recessive polycystic kidney disease (ARPKD). Sections were stained with Lotus Tetragonobolus (LTA) (red), a PT marker, and Arachis Hypogaea (PNA) (brown), a collecting tubule (CT) marker. Representative photos from control specimen, GA17 (A); specimen 2, GA17 (B); specimen 4, GA20 (C); specimen 8, GA24 (D); and specimen 11, PA12 (E). Cysts of proximal tubule origin (asterisks) are present amid morphologically normal proximal tubules, collecting tubules, and CT cysts (B and C). Cysts of proximal tubule origin (asterisks) are present amid an increasing number of CT cysts (D). All cysts are collecting tubules in origin (E). Magnification: ×400 in A; ×500 in B through D; ×250 in E.

View this table:
  • View inline
  • View popup
Table 1.

Lectin profile of cyst formation and cystic index in human ARPKDa

Discussion

This study demonstrates that human ARPKD, like murine ARPKD, has a transient phase of PT cyst formation during fetal development. There was a gradual shift in the site of cystic nephron involvement, from proximal tubules to collecting tubules in human ARPKD during the fetal period (Table 1). The lesions in early stages of disease in cpk, bpk, and orpk mice consist of dilations exclusively localized to proximal tubules. These PT cysts most likely develop in functioning, nonobstructed nephrons, as indicated by microdissection and normal cellular ultrastructure (1,2,5). This is consistent with microdissection data from cpk mice (5). The contribution of PT cysts to the total population of cysts decreases during disease progression. This is most likely due to restriction of PT cystogenesis to a specific developmental stage in the context of ongoing nephrogenesis and progressive formation of CT cysts (3,5). Regression of PT cysts has never directly been demonstrated in vivo, but has been demonstrated in vitro (8,9,12,13).

In summary, we conclude that human ARPKD, like murine ARPKD, has a transient phase of PT cyst formation during fetal development. These findings suggest that ARPKD is a developmental kidney disease in which the shift in the site of tubular lesions may involve developmental regulation of cystic (and/or modifier) gene expression. Identification of these regulatory elements may provide new insights into segment-specific normal and abnormal kidney differentiation and growth.

Acknowledgments

Acknowledgments

This study was supported by funding from the Polycystic Kidney Research Foundation 97002, Grant DK 51068 from the National Institute of Diabetes and Digestive and Kidney Diseases, and the Deutsche Forschungsgemeinschaft.

Footnotes

  • This study was presented in part at the 31st Annual Meeting of the American Society of Nephrology, October 25-28, 1998, Philadelphia, PA, and has been published in abstract form (J Am Soc Nephrol 9: 383A, 1998).

  • American Society of Nephrology

  • © 2000 American Society of Nephrology

References

  1. ↵
    McDonald RA, Watkins SL, Avner ED: Polycystic kidney disease. In: Pediatric Nephrology, 4th Ed., edited by Holliday MA, Barratt TM, Avner ED, Baltimore, Lippincott, Williams & Wilkins,1999 , pp 459-474
  2. ↵
    Welling LW, Grantham JJ: Cystic and developmental diseases of the kidney. In: The Kidney, 4th Ed., edited by Brenner BM, Rector FC, Philadelphia, Saunders, 1991, pp1657 -1694
  3. ↵
    Nauta J, Ozawa Y, Sweeney WE Jr, Rutledge JC, Avner ED: Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol7 : 163-172,1993
    OpenUrlCrossRefPubMed
  4. ↵
    Moyer JH, Lee-Tischler MJ, Kwon HY, Schrick JJ, Avner ED, Sweeney WE, Godfrey VL, Cacheiro NLA, Wilkinson JE, Woychik RP: Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264:1329 -1333, 1994
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Avner ED, Studnicki FE, Young MC, Sweeney WE Jr, Piesco NP, Ellis D, Fettermann GH: Congenital murine polycystic kidney disease. I. The ontogeny of tubular cyst formation. Pediatr Nephrol1 : 587-596,1987
    OpenUrlCrossRefPubMed
  6. ↵
    Zerres K, Mücher G, Becker J, Steinkamm C, Rudnik-Schöneborn S, Heikkilä P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM: Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76:137 -144, 1998
    OpenUrlCrossRefPubMed
  7. ↵
    Avner ED, Sweeney WE Jr: Polypeptide growth factors in metanephric growth and segmental nephron differentiation. Pediatr Nephrol 4:372 -377, 1990
    OpenUrlCrossRefPubMed
  8. ↵
    Pugh JL, Sweeney WE Jr, Avner ED: Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int 47: 774-781,1995
    OpenUrlCrossRefPubMed
  9. ↵
    Sweeney WE, Futey L, Frost P, Avner ED: In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor. Kidney Int 56: 406-414,1999
    OpenUrlCrossRefPubMed
  10. ↵
    Fetterman GH, Shuplock NA, Philipp FJ, Gregg HS: The growth and maturation of human glomeruli and proximal convolutions from term to adulthood. Pediatrics 23:601 -619, 1965
    OpenUrl
  11. ↵
    Loud AV, Aneresa P: Morphometric analysis of biological processes. Lab Invest 50:250 -261, 1984
    OpenUrlPubMed
  12. ↵
    Avner ED, Sweeney WE Jr, Piesco NP, Ellis D: Regression of genetically determined polycystic kidney disease in murine organ culture. Experientia 42:77 -80, 1986
    OpenUrlCrossRefPubMed
  13. ↵
    Avner ED, Sweeney WE Jr, Ellis D: In vitro modulation of tubular cyst regression in murine polycystic kidney disease. Kidney Int 36: 960-968,1989
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 11 (4)
Journal of the American Society of Nephrology
Vol. 11, Issue 4
1 Apr 2000
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Proximal Tubular Cysts in Fetal Human Autosomal Recessive Polycystic Kidney Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Proximal Tubular Cysts in Fetal Human Autosomal Recessive Polycystic Kidney Disease
KOICHI NAKANISHI, WILLIAM E. SWEENEY, KLAUS ZERRES, LISA M. GUAY-WOODFORD, ELLIS D. AVNER
JASN Apr 2000, 11 (4) 760-763; DOI: 10.1681/ASN.V114760

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Proximal Tubular Cysts in Fetal Human Autosomal Recessive Polycystic Kidney Disease
KOICHI NAKANISHI, WILLIAM E. SWEENEY, KLAUS ZERRES, LISA M. GUAY-WOODFORD, ELLIS D. AVNER
JASN Apr 2000, 11 (4) 760-763; DOI: 10.1681/ASN.V114760
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Reciprocal Spatiotemporally Controlled Apoptosis Regulates Wolffian Duct Cloaca Fusion
  • DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN
  • BPI Fold-Containing Family A Member 2/Parotid Secretory Protein Is an Early Biomarker of AKI
Show more BRIEF COMMUNICATION

Cited By...

  • Cystin gene mutations cause autosomal recessive polycystic kidney disease associated with altered Myc expression
  • Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models
  • Incompletely Penetrant PKD1 Alleles Mimic the Renal Manifestations of ARPKD
  • Mutations in zebrafish leucine-rich repeat-containing six-like affect cilia motility and result in pronephric cysts, but have variable effects on left-right patterning
  • The Autosomal Recessive Polycystic Kidney Disease Protein Is Localized to Primary Cilia, with Concentration in the Basal Body Area
  • Genetics and Pathogenesis of Polycystic Kidney Disease
  • Segment-Specific c-ErbB2 Expression in Human Autosomal Recessive Polycystic Kidney Disease
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire